250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Health Care Startup Investors in Finland

A list of 50 angel investors and VC funds that invest in Health care startups based in Finland. We rank investors based on the number of investments they made in Health care companies from Finland. We update this investor list every month.

Top 50 Health Care Startup Investors in Finland

Investor Health Care Finland investments
Butterfly Ventures 18
Lifeline Ventures 17
Tesi 16
Finnvera Venture Capital 16
Icebreaker.vc 11
Voima Ventures 11
Innovestor 11
Business Finland 10
Ali Omar 8
Inventure 7
Springvest 7
Reaktor Ventures 6
Redstone 6
Visionplus 5
Leena Niemistö 4
Maki.vc 4
Novartis Venture Fund 4
Oy Hammaren & Co Ab 4
Nidoco 4
VTT Ventures 4
Jyri Engestrom 3
First Fellow Partners 3
Cor Group 3
Stefan Lindberg 3
Sitra 3
Karolinska 3
M Ventures 3
EQT Life Sciences 2
Broadview Ventures 2
Kustaa Piha 2
Mikael Hed 2
Sofinnova Partners 2
Lynx Capital 2
Conor Venture Partners 2
Athensmed 2
HealthCap 2
Gorilla Capital 2
Mika Ihamuotila 2
Henry Nilert 2
Anssi Vanjoki 2
Superhero Capital 2
Johannes Schildt 2
Elias Aalto 2
Pontos Group 2
Capricorn Partners 2
Vesalius Biocapital Partners 2
Nostetta Ventures 2
Metsola Ventures 2
European Investment Bank 2
Nina Capital 2
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Butterfly Ventures VC Fund · Oulu, Oulu, Finland · 3 investments in the past 12 months
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Seed, Funding Round, Pre-Seed
  • Finland, Sweden, Norway
Portfolio highlights
  • RiACT — Software for robots. Real-time development platform for creators and users of flexible robot applications.
  • 10Lines — 10Lines is developing autonomous parking lot marking robots and technological solutions to significantly increase productivity in the industry of pavement marking. Our solutions are helping striping businesses do their work much more productively with a smaller environmental footprint.
  • Flow Computing — Flow's Parallel Processing Unit (PPU) gives 100X CPU performance for demanding applications, such as locally-hosted AI and general-purpose parallel computing.
Lifeline Ventures VC Fund · Helsinki, Southern Finland, Finland · 3 investments in the past 12 months
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more
Investment focus
  • Software, Health Care, E-Commerce
  • Seed, Series A, Funding Round
  • Finland, United States, United Kingdom
Portfolio highlights
  • Droppe — Order work equipment directly from manufacturers. Support small businesses and source more responsibly from local and European manufacturers. Order from several suppliers at the same time with one shopping cart. Test samples for free and order products for your workplaces without extra hassle. Find nitrile gloves, protective clothing, work gloves, work accessories, disposable gloves, disinfectants, sanitizers and other supplies in one place.
  • Risk Ledger — Risk Ledger ensures your supply chain security by providing tools to run and respond to cyber security-led, third-party risk management programmes at scale.
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Tesi VC Fund · Helsinki, Southern Finland, Finland · 5 investments in the past 12 months
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more
Investment focus
  • Software, Manufacturing, Health Care
  • Funding Round, Series A, Series B
  • Finland, United States, Argentina
Portfolio highlights
  • Seaber — Seaber is a cloud-based real-time planning, optimisation and communication solution for bulk cargo & vessels. Our solution improves the efficiency of bulk & break bulk charterers, shipowners & brokers through schedule planning and stakeholder communications over the lifecycle of a voyage.
  • Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
  • Basemark — Basemark: The automotive AR company - provider of software solutions and toolchains for automotive AR application development.
Finnvera Venture Capital VC Fund · Kuopio, Eastern Finland, Finland
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Funding Round, Series A
  • Finland, United States, Switzerland
Portfolio highlights
  • Enfuce — Unlock growth with our card issuing solutions. Our expertise in issuer processing can turn your ambitious vision into a reality.
  • Nordcloud — Nordcloud is a European leader in public cloud infrastructure solutions and cloud-native application services. Since 2011 we have completed more than 500 deployments to help our enterprise customers gain the maximum benefits of the cloud, including security, agility, scalability and overall cost-savings.
  • Aurealis Pharma — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Icebreaker.vc VC Fund · Helsinki, Southern Finland, Finland · 4 investments in the past 12 months
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Pre-Seed, Seed, Series A
  • Finland, Estonia, Sweden
Portfolio highlights
  • LumiDB — LumiDB allows you to put all your 3D scan data, from point clouds to mesh models, into a single repository, accessible through a straightforward API. We provide an elegant API, optimized performance, and ease of use.
  • Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
  • Tab — Tab is the API-first company that enables smart receipts to arrive straight to your mobile bank app, all linked to your payment card. We help merchants deliver a seamless checkout experience and to unlock new avenues for post-sale engagement, banks to offer better user experiences & reducing customer support costs and consumers can wave goodbyeto lost receipts, tedious expense reporting processes and a more engaging banking experience.
Voima Ventures VC Fund · Helsinki, Southern Finland, Finland · 8 investments in the past 12 months
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more
Investment focus
  • Biotechnology, Health Care, Medical Device
  • Seed, Pre-Seed, Funding Round
  • Finland, Sweden, Norway
Portfolio highlights
  • NADMED — The standard of NAD measuring
  • Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
  • Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
Innovestor VC Fund · Helsinki, Southern Finland, Finland · 3 investments in the past 12 months
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more
Investment focus
  • Software, Health Care, Manufacturing
  • Seed, Funding Round, Series A
  • Finland, Denmark, Sweden
Portfolio highlights
  • Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
  • Kausal — Kausal helps cities turn their climate goals into action through a digital platform that enables smarter collaboration around key data.
  • Confidentialmind — The ConfidentialMind software stack enables you to integrate AI-solutions such as language models into your workflows and processes without data leaks to third parties. We will find a way to protect your data.
Business Finland VC Fund · Helsinki, Southern Finland, Finland · 13 investments in the past 12 months
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more
Investment focus
  • Software, SaaS, Biotechnology
  • Seed, Grant, Debt Financing
  • Finland, United States, United Kingdom
Portfolio highlights
  • Onego Bio — Onego Bio is a cell ag company, specialized in animal-free egg white protein. We produce bioalbumen with an innovative precision fermentation process.
  • Social First — We create games that are social experiences, span decades and extend beyond gaming; giving our players platforms to create meaningful relationships with people all across the world.
  • Distance Technologies — Distance Technologies seeks to develop glasses-free XR applications
Ali Omar Angel · Helsinki, Southern Finland, Finland
Ali Omar is a Member of the Finnish Business Angels Network. He attended Aalto University and the University of Oulu.
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Pre-Seed, Angel
  • Finland, United States, Estonia
Portfolio highlights
  • Themo — Themo's innovation is an algorithm that optimizes the price of exchange electricity and the consumption of electricity. Themo offers an easy and environmentally friendly way to save on electricity consumed by heating.
  • GoalProfit — GoalProfit is the world’s first low code retail optimization platform empowering retailers to build customized intelligence applications. It was founded by former IBM executives, Maxim Morozov and Oleg Sidorkin. GoalProfit is on a mission to make big data solutions available for all retailers and help them to survive in a new post-covid reality.
  • Builderhead — Builderhead is a construction management software designed for real estate developers and general contractors. The software combines project development, procurement, and construction management into a streamlined pipeline. We bring an industry spesific Project Development CRM, Bid Management Tools and Project Management Software in one easy-to-useplatform which integrates easily with other most used software in the industry. Even thought the construction industry accounts for 13% of the world’s GDP, there's been a global problem of poor productivity within the industry as productivity growth has increased only 1% over the past 20 years. From the real estate developers and general contractors point of view, the biggest issue is the projects that turn unprofitable unexpectedly. One unprofitable project destroys the whole year profits and another one can bankrupt the entire company. Most of the decisions that affect the success of a project are made before construction begins, but still there are no smart tools available for that stage to help the construction companies avoid unprofitable projects. We solve this global problem by bringing the most critical steps to the success of a construction project on the same platform.
Inventure VC Fund · Helsinki, Southern Finland, Finland · 5 investments in the past 12 months
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Series B
  • Finland, Sweden, Denmark
Portfolio highlights
  • Leya AI — Feel and sound like an English native in 3 months
  • Steep — Business intelligence for modern companies. Steep lets anyone on your team stay on top of your data.
  • Reveel — Say goodbye to paper maps, brochures, and outdated audio guides. Reveel offers digital solutions for destinations such as UNESCO sites, sights, museums, cities, hotels and parks, taking the visitor experience to the next level. Become part of the smart destination movement, enhance the visitor experience, and discover the future of travel.
Springvest VC Fund · Helsinki, Southern Finland, Finland · 4 investments in the past 12 months
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more
Investment focus
  • Biotechnology, Health Care, Analytics
  • Series A, Funding Round, Seed
  • Finland
Portfolio highlights
  • Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
  • Kuva Space — Kuva Space improves life on Earth through daily, space-borne hyperspectral imaging and AI. We offer Earth observation solutions for more sustainable business.
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Reaktor Ventures VC Fund · Helsinki, Southern Finland, Finland
Reaktor Ventures has moved to the next phase by focusing its efforts to actively supporting current portfolio companies. This means that the fund has ended its investment period and is not investing into new companies. Between 2013 and 2018 we have invested into 42 different companies and one early stage fund. We will naturally keep makingfollow-up investments to current portfolio companies.
Show more
Investment focus
  • Software, Internet, Health Care
  • Seed, Pre-Seed, Series A
  • Finland, Germany, United States
Portfolio highlights
  • Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
  • Swappie — Buy refurbished iPhones at an affordable price - Swappie offers refurbished and cheap iPhones with a free 12-month Swappie warranty.
  • Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
Redstone VC Fund · Berlin, Berlin, Germany · 15 investments in the past 12 months
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Series A, Funding Round
  • Germany, Finland, Switzerland
Portfolio highlights
  • Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
  • Crafthunt — Find your dream job - Discover Crafthunt – Europe's largest platform for construction site jobs.Browse new jobs anonymously without being discovered by your current employer.Discover jobs for site managers, foremen, bricklayers, plant mechanics, and more...Save time in your job search and also be proactively approached by companiesacross 21 languages.Sign up and discover the best engineering offices, construction companies & craft businesses in Europe with Crafthunt!
  • Wave Photonics — Wave Photonics utilizes computational techniques to accelerate integrated photonics product designs.The company is developing a platform that provides optimized designs and streamlined integration between the supply chain using a software tool for predicting the performance and variation of a component for a given fabrication process and anoptimizer to generate a foundry-specific component library.Wave Photonics is headquartered in Bristol, Bristol.
Visionplus VC Fund · Helsinki, Southern Finland, Finland
WE HELP YOU TO GROW FASTER!
Show more
Investment focus
  • Software, Information Technology, Internet
  • Seed, Funding Round, Series A
  • Finland, United States, United Kingdom
Portfolio highlights
  • Pebble — Pebble is a electric vehicle manufacturing startup.
  • Transfluent — Professional translations for all business needs. Fast. Easy.
  • BetterDoctor — BetterDoctor helps validate and deliver accurate provider data to health plans, health systems, and hundreds of other companies via its API — from startups to publicly traded ones. This ultimately helps achieve the mission of helping consumers find the healthcare they need.Today, BetterDoctor's data platform and APIs power 9 health plans,350 companies, 1,500 developers, helping millions of people find the right doctor each month. Health Plans BetterDoctor uses multi-modal outreach to drive providers to attest their information on BetterDoctor's online portal. API PartnersBetterDoctor brings transparency to doctor data. Their real-time platform, master database and API services enable everyone to add doctor data to their systems, websites and applications. Today, BetterDoctor API and data tools power health insurance companies, healthcare startups and doctor search tools. https://betterdoctor.com/developers
Leena Niemistö Angel · Helsinki, Southern Finland, Finland
Leena Niemistö
Show more
Investment focus
  • Health Care, Software, E-Commerce
  • Seed, Funding Round, Pre-Seed
  • Finland, United States
Portfolio highlights
  • #Rens — RENS Original is the World's First Sneaker made from recycled coffee and plastic. We know you've been drinking it, now it is time to wear it.
  • Vapaus — A circular economy startup Vapaus provides sustainable mobility solutions – Employee benefit bicycles and shared electric vehicles as a ready-to-use serviceWith its services, Vapaus supports customers’ to create and strengthen a better experience of the work community, to save on the costs of commuting and business travels, and to move towardssmarter and more environmentally friendly modes of transport, both at work and in employees’ leisure time.Every kilometer traveled by the Vapaus mobility solution removes carbon dioxide from the air, helping not only the environment but also customers on their way to carbon neutrality. The mission of Vapaus is to be a global leader when it comes to sustainable Corporate Mobility.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
Maki.vc VC Fund · Helsinki, Southern Finland, Finland · 4 investments in the past 12 months
Maki.vc is an early-stage venture capital firm partnering with deep tech & brand-driven startups obsessed with challenging category norms.
Show more
Investment focus
  • Software, E-Commerce, Information Technology
  • Seed, Series A, Funding Round
  • Finland, Germany, United Kingdom
Portfolio highlights
  • CardioSignal — Access information about your heart health in just one minute using your phone.
  • Magic Feedback — Magic Feedback is an AI business creating a platform that compiles user reviews into one location and analyzes everything automatically using its own AI.
  • Distance Technologies — Distance Technologies seeks to develop glasses-free XR applications
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 2 investments in the past 12 months
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Hyku — Hyku Biosciences is developing the next generation of covalent medicines by targeting histidine, tyrosine and lysine binding pockets in disease-causing proteins.
  • Exsilio Therapeutics — Exsilio's method is based on naturally occurring genetic elements that can accurately insert new genes into cells via RNA intermediate templates. Exsilio employs predictive in-silico modeling and wet lab-based experiments to create such elements for accurate insertion of therapeutic genes into safe harbor regions of disease-relevant cells.
  • Enterprise Therapeutics — Enterprise Therapeutics is a drug discovery company dedicated to the researchand development of novel therapies for the treatment of respiratory diseases.In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlyingmechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Oy Hammaren & Co Ab VC Fund · Finland, Minnesota, United States
Oy Hammaren & Co Ab provides financial services and insurance activities.
Show more
Investment focus
  • Health Care, Wellness, GreenTech
  • Funding Round, Angel, Series A
  • Finland
Portfolio highlights
  • Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • Heltti — We are Heltti! We help people and knowledge workplaces feel better.
  • NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
Nidoco VC Fund · Stockholm, Stockholms Lan, Sweden · 3 investments in the past 12 months
Nidoco AB is a Swedish investment company whose strategy is to create long-term value through active ownership of public and private companies.
Show more
Investment focus
  • Health Care, Software, Artificial Intelligence
  • Seed, Funding Round, Series B
  • Finland, Sweden, Estonia
Portfolio highlights
  • Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
  • eMabler — We accelerate our customers' business growth by convenience in eMobility with our API-first platform
  • Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
VTT Ventures VC Fund · Espoo, Southern Finland, Finland
VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?
Show more
Investment focus
  • Biotechnology, Manufacturing, 3D Technology
  • Seed, Funding Round, Series A
  • Finland
Portfolio highlights
  • Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
  • Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Jyri Engestrom Angel · San Francisco, California, United States
Jyri Engeström is an Investor and Partner of Yes VC. He attended Lancaster University
Show more
Investment focus
  • Software, E-Commerce, Apps
  • Seed, Angel, Series A
  • United States, Finland, France
Portfolio highlights
  • Jow — Jow is a grocery shopping app that simplifies shopping and gives advice of what to eat. This app offers free and simple recipes that adapt to the customer's taste. It automatically creates a customized menu with delicious recipes and fills the cart with all the ingredients necessary for cooking.Jow was founded in 2017 and is headquartered inParis, France.
  • Spell — Operationalizing AI for NLP, Computer Vision, and Speech Recognition has never been easier
  • Orchid Labs — Orchid Labs is an open-source project committed to ending surveillance and censorship on the internet. Orchid uses an overlay network built upon the existing internet, which is driven by a peer-to-peer tokenized bandwidth exchange, creating a more inclusive, liberated internet. Orchid Labs was founded in 2017 by Dr. Steven Waterhouse, Jay Freeman,Brian J. Fox, Gustav Simonsson, and Stephen Bell.
First Fellow Partners VC Fund · Helsinki, Southern Finland, Finland · 2 investments in the past 12 months
A private investment firm run by Risto Siilasmaa and Kim Groop. Grounded in a deeply held set of values around entrepreneurship, trust, integrity and helping solve the world’s problems. We partner with strong and ambitious technology entrepreneurs driven by a mission to fix or build something important in the world.
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Series A, Funding Round
  • Finland, United States, Estonia
Portfolio highlights
  • LumiDB — LumiDB allows you to put all your 3D scan data, from point clouds to mesh models, into a single repository, accessible through a straightforward API. We provide an elegant API, optimized performance, and ease of use.
  • Vuo AI — Building blocks for advanced AI-based applications
  • The Upright Project — Upright enables smarter decision-making for investors, companies and governments by quantifying the net impact of companies.
Cor Group VC Fund · Oulu, Oulu, Finland
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Seed, Pre-Seed, Series A
  • Finland
Portfolio highlights
  • Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
  • Nightingale Health — The most advanced health check for the health industry.
Stefan Lindberg Angel · Helsinki, Southern Finland, Finland
Stefan Lindberg is co-owner of YSUB.
Show more
Investment focus
  • Nutrition, Wellness, Fruit
  • Seed, Pre-Seed
  • Finland
Portfolio highlights
  • YSUB — YSUB produces a beverage containing hemp - lemonade with a hint of hemp seeds, soothing botanicals, and some vitamins. It also has CBD beverage, but cannot sell due to regulations in Finland and other Nordic countries and is trying to create a campaign to create awareness.
  • Vegemi — Vegemi is a free smartphone app that promotes eating fruits and vegetables through gaming. The software was designed with the entire family in mind, but especially to demonstrate youngsters the health advantages of fruits and vegetables in a way that motivates and inspires them.
  • StepOut.pro — A digital platform for fitness & wellness freelancers to streamline their business activities
Sitra VC Fund · Helsinki, Southern Finland, Finland
Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.
Show more
Investment focus
  • Health Care, Biotechnology, Therapeutics
  • Funding Round, Series A, Series C
  • Finland, The Netherlands
Portfolio highlights
  • Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • SET Ventures — Venture capital firm focused broadly on innovative energy generation, distribution storage and efficiency.
Karolinska VC Fund · Solna, Stockholms Lan, Sweden
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Funding Round, Seed, Series A
  • Sweden, Denmark, United States
Portfolio highlights
  • PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
  • OssDsign AB — Giving patients back the life they deserve, Catalyst nanosynthetic bone graft, orthobiologics
  • Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
M Ventures VC Fund · Amsterdam, Noord-Holland, The Netherlands · 13 investments in the past 12 months
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
  • Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
EQT Life Sciences VC Fund · Amsterdam, Noord-Holland, The Netherlands · 15 investments in the past 12 months
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland
Portfolio highlights
  • Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
  • Binx Health — Binx Health is creating new categories of healthcare solutions that deliver on-demand testing to people where they need it most. With its proprietary, desktop, PCR-based point-of-care testing platforms and consumer mobile offerings, the company is redefining “convenient care” for the modern consumer
  • Vico Therapeutics — Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies for rare neurological disorders. The company discovers, develops, and delivers therapies for CNS disorders. Its initial focus is on SCA which is a subgroup of hereditary ataxia, HD which is a neurodegenerative disorder, and RTT-a neurodevelopmental disorder primarilyaffecting girls that enable clients with providing therapy for it.Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Judith van Deutekom, and Gail Mandel and it is headquartered in Leiden, The Netherlands.
Broadview Ventures VC Fund · Boston, Massachusetts, United States · 2 investments in the past 12 months
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Seed, Debt Financing
  • United States, Israel, Denmark
Portfolio highlights
  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
  • Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
Kustaa Piha Angel · Helsinki, Southern Finland, Finland
Healthcare business development, management, and investing. Very good knowledge on healthcare services and public health. Kustaa Piha is interested in new business and investment opportunities and better ways of producing excellent healthcare services.
Show more
Investment focus
  • Health Care, Medical, mHealth
  • Seed, Funding Round
  • Finland
Portfolio highlights
  • Sooma — Sooma provides unique therapy solutions that combine effectiveness with ease-of-use. Therapies are based on tDCS method.
  • Klinik
  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
Mikael Hed Angel · Greater Los Angeles Area, California, United States
Investor, Executive Chairman at Kaiken Entertainment Ltd.
Show more
Investment focus
  • E-Commerce, Consumer Electronics, Hardware
  • Seed, Angel, Series B
  • Finland, Lithuania
Portfolio highlights
  • Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • CGTrader — Join the fastest-growing 3D model marketplace today!
  • Loupedeck — Loupedeck custom consoles offer analog control with digital precision for effortless creative workflow. Shop now with free shipping!
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 21 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • deepc — The Radiology AI Platform - Your effortless access to AI
  • Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
  • Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
Lynx Capital VC Fund · Shanghai, Shanghai, China
cross-border, healthcare, life science, investment, VC, China, US
Show more
Investment focus
  • Therapeutics, Biotechnology, Pharmaceutical
  • Series A
  • Finland
Portfolio highlights
  • Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
  • Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Conor Venture Partners VC Fund · Espoo, Southern Finland, Finland
Conor Venture Partners is a new breed technology venture capital fund and management company. Conor invests in early-stage companies originating from Nordic and Baltic countries. Investment areas include information and communications technology, embedded software, semiconductor technology, electronics, new materials and optics.
Show more
Investment focus
  • Software, Analytics, Semiconductor
  • Series A, Series B, Seed
  • Finland, United States, Sweden
Portfolio highlights
  • TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
  • Blackwood Seven | Part of Kantar Group — Attribute, predict and optimize the business outcome of marketing and media plans with Blackwood Seven's Unified Marketing Modeling platform.
  • Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.
Athensmed VC Fund
Athensmed Oy
Show more
Investment focus
  • Health Care, Medical, mHealth
  • Seed, Series A, Funding Round
  • Finland
Portfolio highlights
  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
  • VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
HealthCap VC Fund · Stockholm, Stockholms Lan, Sweden
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Funding Round
  • United States, Sweden, France
Portfolio highlights
  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
  • Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
Gorilla Capital VC Fund · 2 investments in the past 12 months
Gorilla Capital invests in early stage Finnish, Swedish, Danish and Estonian technology companies
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Pre-Seed, Seed, Series A
  • Finland, Estonia, Sweden
Portfolio highlights
  • Kwizie — Kwizie transforms passive video consumption into fun multiplayer quiz games with AI. Share a QR code or link to anyone, anywhere, in seconds!
  • Clevenio — Clevenio is a leading provider of innovative healthcare management solutions, dedicated to simplifying the complexities of healthcare administration while improving patient care. The platform offers a comprehensive suite of tools and features designed to optimize every aspect of healthcare management, from appointment scheduling and medical billingto electronic health records (EHR) and telemedicine capabilities. Clevenio empowers healthcare providers to streamline their workflows, reduce administrative burdens, and enhance the overall patient experience.
  • Jungle AI — Jungle uses artificial intelligence to predict component failure, and poor performance in an advanced asset management software.
Mika Ihamuotila Angel
Mika Ihamuotila - Board of Directors @ Rovio Entertainment Corporation
Show more
Investment focus
  • Sustainability, FinTech, Internet
  • Funding Round, Seed, Post-IPO Equity
  • Finland
Portfolio highlights
  • Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • Sulapac — Sulapac brings solutions to the global plastic waste problem with biodegradable packaging innovation.Sulapac combines luxury, sustainability, and unlimited design possibilities. Sulapac packages can be manufactured using injection molding, extrusion, and blow molding techniques. Sulapac has comparable properties to plastics and by using Sulapacbarrier coatings water, oil, and oxygen barrier properties can be further improved.
  • NoHo Partners — NoHo Partners Plc is a Finnish restaurant group behind approximately 250 restaurants, bars, pubs, nightclubs and entertainment centres. The name derives from the words ‘Nordic Hospitality Partners’, which communicate the key goals, opportunities and strengths of the Group.
Henry Nilert Angel · Helsinki, Southern Finland, Finland
Henry Nilert
Show more
Investment focus
  • Software, Health Care, B2B
  • Seed, Pre-Seed
  • Finland, Latvia, United States
Portfolio highlights
  • Nordigen — Nordigen is a free open banking API that provides PSD2 data connections to all major European banks.
  • GoalProfit — GoalProfit is the world’s first low code retail optimization platform empowering retailers to build customized intelligence applications. It was founded by former IBM executives, Maxim Morozov and Oleg Sidorkin. GoalProfit is on a mission to make big data solutions available for all retailers and help them to survive in a new post-covid reality.
  • Inscripta — Inscripta is the most trusted and most cost-efficient dictation and transcription service. Our solution is mainly in use in healthcare, but we also provide services to other industries where highly trained professionals can benefit from not having to waste their time on routine documentation work.
Anssi Vanjoki Angel · Helsinki, Southern Finland, Finland
As Executive Vice President and General Manager of Multimedia, Nokia, Anssi Vanjoki heads a business group that is responsible for developing Nokia Nseries multimedia computers and associated experiences and services. This fast growing segment of consumer electronics will shape our lives in a fundamental way. A highly respected brand authoritywith over 25 years of marketing experience, Anssi has been a driving force in Nokia's efforts to address the mobile markets. His work has focused on developing Nokia's brand durability, loyalty and continuity, while, at the same time, advancing Nokia's vision of a mobile world. Anssi joined Nokia in 1991 and was named Vice President, Sales, Nokia Mobile Phones, before his promotion in 1994 to Senior Vice President, Nokia Mobile Phones Europe and Africa. In 1998 he was made Executive Vice President, Nokia Mobile Phones Europe and Africa and became a member of the Group Executive Board of Nokia. In addition, in 1999, Anssi took responsibility for Nokia's Digital Convergence Unit and, in 2002, also headed up the Business Unit Management. He was appointed to his present position on January 1st 2004. Prior to joining Nokia, Anssi held a variety of management positions at 3M Corporation. Anssi is the Chairman of the Board of Amer Group, and was a member of the Governing Committee of the European Foundation for Quality Management 2001 - 2003. He is a Knight, 1st Class, of the Order of the White Rose of Finland. Anssi holds a master's degree in economics from the Helsinki School of Economics and Business Administration.
Show more
Investment focus
  • Medical, Hardware, Health Care
  • Angel, Series A
  • Finland
Portfolio highlights
Superhero Capital VC Fund · Helsinki, Southern Finland, Finland · 5 investments in the past 12 months
Early-stage VC searching for the next Superheroes.
Show more
Investment focus
  • Software, Information Technology, Internet
  • Seed, Pre-Seed, Funding Round
  • Finland, Estonia, Lithuania
Portfolio highlights
  • eMabler — We accelerate our customers' business growth by convenience in eMobility with our API-first platform
  • Fractory — Custom metal fabrication services for project and series manufacturing. 1-1 engineering support and payment terms for companies.
  • Flow Computing — Flow's Parallel Processing Unit (PPU) gives 100X CPU performance for demanding applications, such as locally-hosted AI and general-purpose parallel computing.
Johannes Schildt Angel · Stockholm, Stockholms Lan, Sweden
Johannes Schildt, a true serial entrepreneur who founded or co-founded more than 3 companies, started his first company while still in school. Schildt later made a meteoric career at Stardoll working alongside people like Henrik Torstensson & Marcus Gners. Johannes successfully launched Stardoll's first official Facebook game, reaching1,000,000 monthly unique users within 3 months after launch. Today, Johannes is the CEO & Co-founder of Kry. By combining new technology with leading medical expertise KRY has built a platform to make healthcare digital.
Show more
Investment focus
  • Health Care, Software, Apps
  • Seed, Angel, Pre-Seed
  • Sweden, Finland, United States
Portfolio highlights
  • Helppy — Helppy is redefining elderly care. We are the trusted companion of seniors and their families. Helppy is a personalized elderly care platform supported by technology. We provide personal care, family support and a broad range of additional services to elderly at home.
  • Valar Labs — AI to Make Oncologists Smarter
  • Vital — Vital is an API for wearables, medical devices and lab tests. We make it easy to connect to hundreds of wearables such as Oura, Garmin, Fitbit, Omron, and deliver at home custom branded lab tests through an API.
Elias Aalto Angel · Helsinki, Southern Finland, Finland · 2 investments in the past 12 months
Elias Aalto is Wolt's Advisor and a Co-Founder before that.
Show more
Investment focus
  • Internet, News, Video
  • Seed, Pre-Seed, Series A
  • Finland, Sweden, Estonia
Portfolio highlights
  • Cluby — Cluby is a technology platform that provides restaurants with the best tools for managing and communicating with loyal consumers.
  • ArcticStartup — ArcticStartup is helping to build communities with uncapped opportunities through media, events, PR and consulting since 2007.Launched in 2007 by Antti Vilpponen and Miikka Kukkosuo as founding writers and getting out two-three articles a week, ArcticStartup quickly started gaining traction. In 2008 Ville Vesterinen and Karri Saarinen joinedthe founding team and ArcticStartup launched its own that were at first held in a small bar of Dubrovnik in Helsinki. Both the media and events started going international in 2009, expanding to the neighbouring Nordics & Baltics. This growth continued until 2012, when the company nearly shut-down as the founders wanted to move-on to other projects. At that point Dmitri Sarle and Greg Anderson took over the company and re-founded ArcticStartup with Jan Ameri joining very shortly.
  • Flowstep — Flowstep is a copilot that helps you create better designs, 10x faster. Just type and get user flows, high-fidelity UI, JTBD and more.
Pontos Group VC Fund · Helsinki, Southern Finland, Finland
Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.
Show more
Investment focus
  • Genetics, Hospital, Automotive
  • Funding Round
  • Finland
Portfolio highlights
  • Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of €56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
  • Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Capricorn Partners VC Fund · Leuven, Vlaams-Brabant, Belgium
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Funding Round, Series B, Series A
  • Belgium, United States, The Netherlands
Portfolio highlights
  • Chainels — The tenant experience app for every property in your portfolio. Save time, gain insights and collaborate with your tenants all in one place.
  • VoxelSensors — Spatial and Empathic Computing. Bringing empathic abilities to XR and mobile devices by understanding user attention and intent.
  • Electric Hydrogen — Electric Hydrogen designs and builds low-cost, high-efficiency green hydrogen systems to economically decarbonize industrial sectors like ammonia and steel
Vesalius Biocapital Partners VC Fund · Strassen, Luxembourg, Luxembourg · 4 investments in the past 12 months
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • Belgium, Germany, The Netherlands
Portfolio highlights
  • inHEART — inHEART is a spin-off from IHU Liryc and Inria, two top-tier research centers respectively in cardiac electrophysiology and digital science and technology, that develops software solutions for medical image analysis and cardiac modeling in heart rhythm disorders. inHEART vision is to make the bridge between radiology and cardiology to become aworldwide leader in image-guided diagnosis, therapy planning and navigation software solutions for heart rhythm disorders.
  • Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
  • Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
Nostetta Ventures VC Fund · Kuopio, Eastern Finland, Finland
Nostetta Ventures is a venture capital company investing in growth companies mainly in the North Savo region.
Show more
Investment focus
  • Health Care, Medical Device
  • Seed, Pre-Seed
  • Finland
Portfolio highlights
  • Marginum — Pioneering the next-generation quantitative surgical techniques.
Metsola Ventures VC Fund · Espoo, Southern Finland, Finland
Metsola Ventures
Show more
Investment focus
  • Medical, mHealth, Health Care
  • Series A
  • Finland
Portfolio highlights
  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
  • Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
European Investment Bank VC Fund · Luxembourg, Luxembourg, Luxembourg · 15 investments in the past 12 months
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Debt Financing, Post-IPO Debt, Funding Round
  • France, Germany, The Netherlands
Portfolio highlights
  • Rohlik — Rohlik is an innovative grocery delivery startup that offers a 90-minute same-day delivery service. Since its inception, Rohlik has been growing and is on track to EUR 300 mil. revenues in 2020. Rohlík was founded in 2014 by Marek Sacha and Tomas Cupr and is headquartered in Karlín, Hlavni mesto Praha, Czech Republic.
  • Eldrive — The largest charging point operator in Eastern Europe | Our network is expanding rapidly yet our focus is fixed on renewables, for a greener future. We provide AC & DC charging across Bulgaria, Romania and Lithuania.
  • ABN AMRO Bank — Als bank leggen wij de focus op inclusiviteit, duurzaamheid, sociaal ondernemen, innovatie, dagelijkse bankzaken en meer.
Nina Capital VC Fund · Barcelona, Catalonia, Spain · 6 investments in the past 12 months
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • United States, United Kingdom, Austria
Portfolio highlights
  • Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
  • Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
  • Zetta Genomics — At Zetta Genomics our products and services are empowering the application of genomic data to improve health outcomes for millions of patients around the world.
Investors by industry
Investors by country
Investors in Finland by industry